Progress and prospect on treatment for radioiodine-refractory thyroid cancer
Most patients with differentiated thyroid cancer benefit from surgery, radioactive iodine-131 therapy and TSH suppression therapy, resulting in a favorable prognosis. However, once radioactive iodine refractory thyroid cancer (RAIR-DTC) develops, the prognosis becomes significantly poorer, treatment...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Office of China Oncology
2025-01-01
|
| Series: | Zhongguo aizheng zazhi |
| Subjects: | |
| Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1739775845187-2003910516.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|